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5Preface
The EMCDDA is proud to present the Trendspotter Manual: A Handbook for the Rapid 
Assessment of Emerging Drug-related Trends. We are publishing this manual at a time 
when rapidly emerging drug trends and threats demand equally rapid responses. Current 
generations have at their disposal unprecedented communication possibilities, and new 
trends are adopted in their everyday lives at a pace never seen before. A new clothing 
fashion, music genre or food trend emerging on the other side of the globe can be 
picked up in no time, even in the smallest European towns or villages. This observation, 
unfortunately, is also true for drug markets. The same communication tools facilitate the 
marketing and supply of drugs across national boundaries, allowing the rapid spread of new 
and untested substances at global and local levels, among old and new groups of users, 
with often dire consequences for public health. This increasingly complex and dynamic 
reality poses new challenges for those of us tasked with understanding and responding to 
emerging drug trends.
This publication is designed as a user-friendly guide, taking the reader step by step through 
the methodology developed by the EMCDDA to explore emerging drug trends, new patterns 
of use and developing drug markets and technologies. The first trendspotter study was 
carried out in 2011. It investigated regional heroin shortages in Europe and their impact 
on patterns of use and associated harms among heroin-using groups. Since then, the 
trendspotter approach has become an essential tool for the EMCDDA — complementing 
traditional monitoring instruments — in its work to understand and obtain rapid insights 
into Europe’s new drug trends and drug-related phenomena. Among the topics studied 
to date are outbreaks of fentanyl-related deaths, new developments in the MDMA market, 
the emergence of internet drug markets, and recent surges in the availability of powder 
cocaine across Europe. These studies have provided us with a timely understanding of the 
drivers, dimensions and impacts of these new trends. Such results can be invaluable to all 
of those working in the drugs field who may need to respond rapidly to new challenges, 
whether they are policymakers working at national or regional level, or public health or 
law enforcement professionals working on the ground. The Trendspotter Manual has 
been piloted in several national studies and is the central component of an EMCDDA 
training package. We hope that its publication will stimulate the use of the trendspotter 
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methodology by agencies and organisations, whether these are research groups, community 
organisations, government agencies or professionals working in the drugs field, or perhaps 
even those working in other domains. 
The success of the EMCDDA trendspotter studies, as well as the production of this 
handbook, would not have been possible without the participation over the years of 
national and international experts as well as that of our closest partners, the Reitox national 
focal points. 
Alexis Goosdeel
Director, EMCDDA
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9I The 10 things you need to know about the trendspotter methodology
(1) What is a trendspotter study?
A trendspotter study is essentially a rapid information 
assessment that uses multiple social research methods 
to explore a topic of interest or concern. The approach has 
been used by the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) since 2011 to explore a 
range of drug-related topics, including the extent of heroin 
shortages in Europe, fentanyl outbreaks and the role of the 
internet in drug markets. The trendspotter methodology 
has been developed by the EMCDDA as a tool that is used 
alongside and complements other routine drug monitoring 
methodologies. It has generally been utilised to explore 
emerging phenomena and trends that are in their infancy, 
or not covered by existing data sets. 
While the specific aim and objectives of trendspotter 
studies can vary, they usually focus on an issue of 
significant concern and where information is lacking. Often 
the goal is to map and describe a new drug trend or an 
emerging phenomenon, understand the drivers behind 
this change and identify implications for the future. The 
methodology draws heavily on rapid assessment methods 
(Rhodes et al., 2000; Stimson et al., 2009) and mixed 
methods research, and involves the collection of data 
from multiple sources and the use of a number of different 
investigative approaches. By triangulating qualitative 
and quantitative data and systematically drawing on 
expert evidence, the approach results in a rich and in-
depth cross-sectional snapshot. Results can be used to 
inform appropriate and effective decision-making and 
the timely development of practical public health and law 
enforcement responses.
(2) What are the key characteristics of a 
trendspotter study?
A trendspotter study is generally initiated in response to 
a new or emerging drug trend or development for which 
there is considerable uncertainty and limited information 
available. Trendspotter studies are characterised by:
 ■  rapidity — there is a focus on speed of data collection 
and reporting;
 ■  a team approach — with multiple investigators and 
shared responsibilities;
 ■  multidisciplinary engagement — engaging health and 
CHAPTER 1
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social sciences, law enforcement, forensic sciences, 
drug user perspectives, etc., as appropriate;
 ■  a multi-level analysis — local, city, regional, national, 
European levels;
 ■  use of mixed methods — qualitative and quantitative 
approaches;
 ■  use of triangulation — for analysis and for ensuring 
validity of results.
(3) Who is it for?
There is a range of stakeholders who might benefit from 
using this approach. The EMCDDA has undertaken a 
number of these studies to explore emerging drug trends 
at the European level in order to supplement and enhance 
the information collected through routine monitoring 
practices. The method has also been used by national 
drug observatories to explore trends and developments 
at the country level for new topics for which routine data 
were limited. Practically speaking, the method could be 
initiated by many organisations or groups, with or without 
an illicit-drug focus, as long as the necessary resources 
and social research skills are available. Therefore, the 
trendspotter method may be of interest to local, national 
or regional bodies, including research groups, community 
organisations, government agencies, policymakers and 
professionals.
(4) When is it appropriate to use a trendspotter 
approach? (and when not?)
This approach has been developed, and is particularly 
useful, for the investigation of new drug trends and 
emerging phenomena; for example, when there are signals 
coming from a number of sources, and an increased 
understanding of drivers, dimensions and the impact of 
the new trend is required. Examples of such environmental 
signals might include reports from frontline staff of 
increased drug availability, seizures of high-purity products, 
and reports from hospital emergency departments of an 
increase in cases linked to a particular substance. This 
methodology can also be used to explore new patterns of 
use or developing markets or technologies for which limited 
documentation or published information is available. This 
may be because the issue is so new that little has yet been 
written, or that the issue lies outside the area currently 
covered by drug-monitoring systems. From a European 
or international perspective, it is also useful to explore 
whether a phenomenon identified in one country is also 
present in others.
There are many research questions for which the 
trendspotter approach is not appropriate and other social 
research methods provide better answers. For example, 
if numerical data are needed, then quantitative methods 
are preferable. If the research question focuses on ‘what 
works?’, then evaluation approaches should be used. Some 
of the factors indicating that a trendspotter approach 
may or may not be useful are summarised in the table on 
page 16.
(5) Who performs a trendspotter study?
Multidisciplinary engagement and a team approach are 
central to this method. The study is conceived, developed 
and implemented as a team effort, with members from 
different backgrounds and professional disciplines working 
together; for example, health and environmental sciences, 
social sciences, forensic science and law enforcement. 
There is no limit on the size of the team, but between four 
and six members is probably optimal. Within the team, 
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there will need to be a nominated coordinator and a report 
writer (these can be the same person).
Often, a new multidisciplinary team will need to be 
established for the purpose of conducting a trendspotter 
study. At the EMCDDA, we put together a new team for 
each study, depending on the resources available and 
the skills and competencies required of team members. 
Importantly, team members need to have a range of social 
research and analytical skills and report-writing abilities. 
Chairing meetings and facilitating focus groups are 
additional important skills needed within the team.
(6) What methods and tools are used?
Most of the individual methods used when implementing 
a trendspotter study are found in the social sciences 
(surveys, interviews, literature review). What is unique 
to this approach is the process and the way these 
methods are combined. For each study, a core set of 
methods is recommended, and additional methods may 
be included when appropriate. Importantly, the mixed 
methods approach used is underpinned by an analysis 
built on triangulation to enhance the reliability and 
validity of findings. This helps to offset any shortcomings 
associated with the individual methods and provides 
stronger inferences for particular findings. It also allows 
for completeness, as it provides a comprehensive picture 
of the phenomenon being explored through a wide range 
of research questions. As a result, the outcome of the 
trendspotter mixed methods approach is greater than the 
sum of the outcomes of the individual methods.
The core methods and tools used include a data and 
literature review, online expert surveys, expert presentations 
and facilitated group discussions. The use of additional 
methods — such as internet snapshots, key informant 
interviews or social media monitoring — will depend on the 
questions being addressed, the resources available and the 
context of the study. 
(7) What resources are needed?
In terms of human resources, a team of four to six people will 
need to work on the study on a part-time basis for a period of 
around 4 months. The report writer will need additional time 
at the end of the study to draft the output document.
In addition to human resources, additional costs relate to 
an expert meeting and may involve room hire and catering, 
as well as funding travel and accommodation for invited 
experts. Finally, there will be costs linked to the publication 
of the final report; however, there are options here, for 
example, the report might be made available online or 
disseminated electronically.
(8) How long does it take?
The exact length of a study depends on many factors; 
however, studies always take less than a year from initiation 
to report launch and can take as little as 6 months from 
start to finish.
A trendspotter study can be divided into three stages:
 ■  Stage one — planning and preparation (1-2 months).
 ■  Stage two — data gathering and analysis including 
expert meeting (2-4 months).
 ■  Stage three — report writing, peer review and 
dissemination of results (2-3 months).
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This last phase may be longer or shorter, depending on 
whether the report needs to be edited and if production 
time needs to be built in.
(9) What steps are involved in the process?
Figure 1 summarises the main processes involved, while 
a detailed description of the steps to be taken is provided 
in the next chapter of this manual. Not all of the tasks are 
consecutive in practice, as, for example, the planning and 
analysis tasks are ongoing and will overlap with and feed 
into the data gathering process. Importantly, the data 
gathering and analysis takes place in two phases. The first 
phase involves the use of both qualitative and quantitative 
methods by the team and concludes with a preliminary 
analysis of results. The second phase of data gathering 
takes place at a structured expert meeting and functions 
mainly to gather expert opinion and validation, as well as 
using input from experts to enhance and fine-tune the 
study’s analysis and results.
(10) What are the outputs from a study?
The study concludes with the production of a concise report 
on the main findings of the analysis and the conclusions 
drawn. All team members and invited experts are involved 
FIGURE 1
Main steps involved in the trendspotter study methodology
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in the quality checking and peer review process. The results 
need to be timely and can feed into other formal reporting 
mechanisms, such as national reports or policy briefings. 
They can provide input for policy and planning in specific 
areas.
Many other possible outputs can accompany or follow the 
report. These can range from a more in-depth publication 
and a scientific article to web content and related video or 
social media outputs. 
I How to use this manual
This manual is designed to provide a step-by-step guide 
on how to plan and implement a trendspotter study. The 
following four chapters cover planning, research (divided in 
two phases) and dissemination. 
In the following chapters, examples will be used from the 
2016 EMCDDA trendspotter study ‘High-risk drug use and 
new psychoactive substances — results from an EMCDDA 
trendspotter study’. These case studies illustrate how the 
guidance can be put into practice. 
A set of appendices provide basic templates such as a 
planning form, expert meeting agenda and presentation 
guidelines, as well as examples of questionnaires. 
2
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A trendspotter study is particularly useful for investigating 
new drug trends and emerging drug-related phenomena. 
It is important to take some time to identify and carefully 
define the topic to be addressed. The main objective of the 
planning process is to define the study framework that will 
provide the backbone for the study’s data collection and 
analysis. The careful selection of the topic and the aim of 
the study, defining specific objectives to be achieved while 
choosing the right methods to achieve them, are key during 
the planning and preparation processes. Careful planning is 
essential for the study to be smoothly implemented and to 
ensure that all steps are followed in the correct sequence.
To support the planning, a study ‘planning form’ needs 
to be completed to record important decisions (see 
Appendices 1 and 2). This covers the following areas: 
 ■  study framework:
 » topic for the study;
 » rationale for the study;
 » aim and objectives;
 » themes;
 » research questions;
 ■  study methods;
 ■  study outputs;
 ■  team roles and responsibilities;
 ■  expert meeting participants.
I Selection of an appropriate topic for the study
Selection of an appropriate study topic is important and 
can take some time and team reflection (Table 1). While in 
some cases, there may be an obvious topic and clear need, 
very often there may be competing issues and some time 
is needed to review signals and sparse evidence, discuss 
what is most pressing and come to an agreement among 
the team on the topic to be studied.
Central to choosing the right topic for a trendspotter study 
is careful review of all relevant environmental signals picked 
up, including from:
 ■  routine monitoring data;
 ■  early warning systems;
 ■  national reports;
 ■  scientific papers and grey literature;
 ■  expert networks;
 ■  media monitoring.
While bearing in mind that for most new topics, data are 
limited (indeed this is a reason for using the method), you 
will still need to have identified some significant reports 
before starting off the process. It is also important to 
confirm that the topic is of institutional relevance and is of 
interest to potential stakeholders.
CHAPTER 2
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Before finally selecting a topic, it will be important to 
check that the topic meets the criteria for a trendspotter 
study (see Table 1). In some cases, it will be much better 
to choose another approach; for example, a needs 
assessment, a survey, a focus group or an evaluation study. 
At times, a topic may be raised because of 
increased media interest, or decision-makers may make a 
request to investigate a particular topic, although no signals 
have been flagged in the available data sources. To avoid 
carrying out a trendspotter study resulting in no valuable 
findings or just to confirm that there are no signals, you may 
want to consider widening the area under investigation. For 
example, if there has been a single death due to synthetic 
cannabinoids and the media is claiming that this substance 
is flooding the country, although no signals of increased 
availability have been reported, you may want to see if 
signals of increased availability of other new psychoactive 
substances (NPS) are apparent and, if so, carry out a 
trendspotter study on recent changes in NPS availability 
(broader topic), which would also cover the topic of synthetic 
cannabinoids and the role they play within the NPS and 
wider drug markets in the country. As a result, the picture 
obtained through your study will be more comprehensive 
and more informative for your stakeholders.
I Clarifying a rationale
The ‘why are we doing a trendspotter study’ is an important 
starting point for the team and involves providing 
justification and clarifying the need for the study, as well 
TABLE 1 
When and when not to use the trendspotter method
When to use When not to use
An issue of concern is being flagged by multiple 
sources — (signals).
Another method is better suited to answer the 
research question.
It is an important issue or priority area for the agency 
or institution.
The issue is of concern to only a limited number 
of stakeholders. 
An information gap exists on a topic. The issue is either very broad or very narrow and complex. 
There is a need for a multidisciplinary overview. There is already sufficient existing information on a topic.
Understanding is likely to be enhanced by 
triangulation of different sources.
The method does not give added value for 
the investment.
Routine information is delayed or slow to be reported. Only limited signals of a new trend are detected.
An issue is so new that other methods cannot deliver.
Questions raised cannot be answered using 
traditional methods.
Chapter 2 I  Planning the study
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as the reasons for choosing this topic. This might include 
picking up environmental signals, reports of problems, etc. 
The rationale will need to be agreed among the team and 
potential hierarchical superiors and included at the start of 
the planning form.
I Establishing a study aim and objectives
The study aim should be broad, whereas the objectives 
should be more specific. Typically, when the study is 
exploring a new drug trend, the objectives might focus on 
understanding prevalence and patterns of use, related 
harms, market and supply features, and current and 
required responses.
I Identification of main themes
The themes in a trendspotter study are very important. 
Building on the study aim and objectives, the team will 
need to identify a small number of themes that the 
study plans to address. These will form the backbone or 
analytical framework for the study’s data collection and 
analysis. Typically, themes are broad issues, such as drug 
use or drug-related harms, and they may have several 
subcategories. These themes are used throughout the 
study to guide the literature review and to structure the 
surveys and presentations.
I Brainstorming of research questions for each theme
Once the themes have been selected, the team needs to 
brainstorm all the related research questions they would 
like to have answers to in the course of the study.
The research questions are key to the process: they 
guide the data collection in phase 1 as well as the expert 
presentations and facilitated groups in phase 2. They will 
also help to structure the results and the final report.
Some questions fit easily under the main themes and can 
be investigated during the literature review and survey. 
Others will be more general or linked to motivations 
and drivers behind the new trend. These can often be 
addressed during the facilitated group discussions in the 
expert meeting.
For example, imagine there are signals that MDMA use 
among partygoers is increasing, purity is going up and 
hospitals are reporting more cases of MDMA-related 
emergencies. Some research questions on the use and 
supply of MDMA can be researched through a review of the 
latest existing data (e.g. general population survey data, law 
enforcement seizures data, drug checking data, hospital 
emergency data, wastewater analysis, etc.). However, 
research questions pertaining to more transversal and 
contextual aspects, such as the role of MDMA within the 
current stimulant market or questions such as ‘Why are we 
seeing more potent MDMA in my country?’, ‘Where does it 
come from?’, ‘What are the motivations to consume more 
potent and potentially harmful MDMA in my country?’, 
or ‘What are the implications for practice and policy?’, 
will be crucial research questions that will be hard if not 
impossible to answer with the existing data available from 
routine monitoring. You may develop hypotheses based 
on initial findings from the data review, which you can 
then validate or refute by asking transversal or contextual 
research questions during the meeting with the experts.
In summary, research questions can be categorised into 
two levels. Level 1 research questions cover ‘who/how 
many/where/what/etc.’, which should be partially or fully 
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The 2016 EMCDDA trendspotter study focused on the 
topic of problem drug use (PDU) and NPS.
Selection of the 2016 trendspotter study topic involved 
several brainstorming meetings among a small team of 
EMCDDA staff. A review of environmental signals and 
reports initially identified a number of potential issues 
of concern for EU-level drug monitoring. Input on the 
relevance of these issues was gathered through a survey 
of the EMCDDA trendspotter network, and the results 
from the survey pointed to NPS-related topic areas. 
To help make the decision, ‘environmental’ signals 
from both formal and informal data were analysed 
more closely, and sources that pointed to critical new 
developments in Europe’s NPS market were reviewed. 
Aspects that emerged from this review included signs of 
increased and problematic use of NPS among a range 
of demographic groups, including the use of synthetic 
cathinones by opioid and amphetamine injectors, the 
injection of synthetic cathinones by small groups of 
men who have sex with men (MSM), reports of potent 
new synthetic opioids found in heroin products, and 
the problematic use of synthetic cannabinoids by 
marginalised populations in certain countries. These 
signals provided a clear rationale for carrying out a 
trendspotter study on this topic. 
Recognising the complexity of this area, a broad study 
aim was chosen: ‘to map and increase the understanding 
of PDU and NPS in Europe, including the range of 
manifestations, the underlying facilitating factors and 
associated harms and consequences’. More specific 
objectives were identified and aimed to explore:
 ■  main user groups and their characteristics;
 ■  clusters, patterns and trends in use (polydrug use, 
injecting, outbreak or endemic, NPS known or 
adulterants);
 ■  main substances/products used and their effects;
 ■  associated harms and deaths;
 ■  sources of supply (local illicit markets, internet);
 ■  external triggers that may be linked with new use 
or changes in use patterns or stopping use (drug 
shortages, regulation, changes in availability, product 
purity, etc.)
 ■  geographical clusters of problem use — local, city 
level, rural, national, etc.;
 ■  unmet need for health and social interventions.
These objectives provided a starting point for the 
establishment of the study’s themes and subthemes:
 ■  Theme 1. Drug use: prevalence, patterns and trends
 » Subthemes: user groups, MSM and slamming, 
prisoners, etc.
 ■  Theme 2. Motivations for use and markets
 ■  Theme 3. Consequences and harms
 ■  Theme 4. Responses
The study planning form, including aims, objectives, 
definitions and timetable, was then completed and 
agreed by the team.
 Case study example 1 — EMCDDA selection of a topic, aims and objectives 
Chapter 2 I  Planning the study
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For the 2016 EMCDDA trendspotter study on high-risk 
drug use (HRDU) and NPS, the research questions were 
grouped under the study themes as follows:
 ■  Theme 1. Drug use: prevalence, patterns and trends
 » Which risk populations are associated with 
problematic use of NPS in Europe?
 » What is happening with use? Stable, increasing 
trends? Changes in HRDU linked to changes in 
the general population use? Are they new users 
or existing users switching?
 » User characteristics: very marginalised, is there 
an age issue, e.g. young or older users?
 » Are new patterns of use geographically limited or 
EU-wide? Local or global?
 » Is there any association with specific settings — 
streets, prisons, parties?
 » What types of NPS are used by each risk group? 
What patterns of NPS use are observable among 
these risk groups?
 » Which substances are used together — 
combining what/how? What are the main routes 
of administration? 
 » Are there geographical clusters of problem NPS 
use — local, city level, rural, national?
 ■  Theme 2. Motivations for use and markets
 » What are the reasons for use — lack of heroin, to 
avoid detection, sex parties?
 » What external or environmental triggers may 
be associated with new use or changes in use 
patterns or stopping use (e.g. drug shortages, 
regulation, changes in availability, product 
purity)?
 » What role is played by NPS in the overall PDU 
(opioids/stimulants) market?
 ■  Theme 3. Consequences and harms
 » What do we know about NPS-related 
harms and deaths? Are there some biases, 
underestimations, country differences in the data 
available? Are there some typical polydrug use 
patterns related to fatal overdoses?
 » Has there been an increase in acute hospital 
admissions?
 » Are there any links with injection and blood-borne 
virus infections (human immunodeficiency 
virus, hepatitis C virus, hepatitis B virus, other 
infections)?
 ■  Theme 4. Responses
 » Is there an unmet need for health and social 
interventions? 
 » Is there any evidence of the impact of changing 
regulation and laws on patterns of use and 
harm?
 » What are the implications for monitoring and 
health and social responses?
Case study example 2 — Brainstorming research questions linked to themes
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answerable with the literature and data review during 
phase 1. Answers to these level 1 questions can also be 
validated at the expert meeting.
Level 2 research questions correspond to contextual and 
transversal aspects such as ‘Why? (e.g. motivations and 
drivers)’, ‘What are the implications and how might we 
respond?’, and ‘What are the challenges in responding?’, 
which are research questions that will be answerable 
with input and new information obtained from the expert 
meeting (phase 2).
I Selection of methods and analytical outputs
The trendspotter approach combines and triangulates 
a mix of qualitative and quantitative methodologies 
(Figure 2). Together, these methods should help to answer 
the range of research questions, including those focusing 
on who/when/how many/where, as well as the ‘Why?’, 
‘With what implications?’, and the ‘How might we respond 
and what are the challenges in responding?’ questions.
The methods are described in more detail in the next 
chapter, ‘Data collection and analysis (phase 1)’.
 ■  The data collection and analysis is divided into 
two separate phases. The first phase involves data 
collection by the trendspotter team using a number of 
mandatory and possibly some optional methods and 
concludes with a preliminary analysis of the results. 
The second phase involves data collection and analysis 
with external experts, and it takes place in the course 
of a structured expert meeting.
 ■  The mandatory methods for the first phase are: 
 » literature review; 
 » review of existing data sets; 
 » online expert survey.
The results of these methods are summarised in a team 
presentation (see Chapter 3).
The optional methods include additional online surveys, 
internet snapshots, social media and online forum 
analyses, commissioning of new analyses, and user 
interviews. 
FIGURE 2
Two phases of data collection and analysis
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 ■  The mandatory methods for the second phase are:
 » expert presentations;
 » facilitated groups.
The final analysis is summarised in a conclusions 
presentation (see Chapter 4). 
In the planning of the study it is important to designate 
who is responsible for each data gathering method (it can 
be one, two or three team members per method) and all 
details should be inserted into the planning form to keep 
records of the progress and allocation of responsibilities.
I Identification of study outputs
When planning the study, it is necessary to give some 
consideration to the likely outputs. It will be important to 
publish a concise report summarising the main findings.
 ■  Results can feed into other reporting mechanisms 
(for the EMCDDA, study results have informed the 
European Drug Report, country drug reports, policy 
briefings, etc.).
 ■  It might be possible or relevant to develop other 
publications, scientific articles, web content, social 
media outputs, etc. 
 ■  There is a space on the planning form where outputs 
can be specified.
I Establish team roles and responsibilities
Once a topic has been selected, the composition of 
the team to undertake the study will need to be agreed 
and their specific roles and responsibilities allocated. 
Importantly, team members require a range of social 
research skills between them, for example, data analysis 
as well as chairing and facilitating focus groups, and 
knowledge of social science and public health research 
methods, especially qualitative, quantitative and mixed 
methods approaches.
 ■  A team should ideally consist of around four to six 
members who can commit to the time required 
to undertake the study. Members may come from 
the same department or agency or from different 
organisations. 
 ■  It is very important to verify early on that the required 
skills for a trendspotter study exist in the team. It 
is also very helpful if team members have different 
professional expertise and backgrounds. If some 
skills are lacking among the team (such as chairing 
large meetings or facilitating discussion groups), the 
coordinator may seek external support or suggest team 
members to explore available online resources for 
some tips on how to carry out these tasks.
 ■  The two key team roles that need to be agreed at the 
start are the coordinator and report writer:
 » The coordinator supports and motivates members 
throughout the process. He or she must ensure that 
the study is aligned with organisational priorities, 
that the necessary permissions are granted, 
and the required resources are available. The 
coordinator is also responsible for planning and 
establishing a timeline. 
 » The report writer will need to have experience of 
drafting papers or reports based on social research 
methods.
 » The coordinator will need to timetable regular 
meetings with the whole team throughout the 
study (at least once a month).
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Experience shows that allocating responsibilities 
by theme (each member should work on at least one theme 
from the start) rather than by method (one team member 
does the literature review and another does the online 
survey, etc.) will result in a better understanding and 
integration of the overall outcome of the trendspotter study. 
At the EMCDDA, each team member participates in the 
analysis of at least one theme. As a result, each team 
member is involved in the development of the theme-
related questions of the online survey, the team 
presentation at the expert meeting, etc. Specific 
responsibilities, such as facilitating an expert group or 
chairing the meeting, will be an additional responsibility 
depending on the skills of the team members. 
For the 2016 trendspotter on HRDU and NPS, the 
mandatory methods were divided up as follows:
Literature review — thematic areas
 ■  HRDU, injecting drug use, characteristics, patterns 
and trends.
 ■  MSM and slamming.
 ■  NPS use in prisons.
 ■  External and environmental triggers.
 ■  NPS-related harms and deaths.
Review of data sources
 ■  Problem drug use indicators and NPS.
 ■  Treatment demand indicators and NPS.
 ■  Drug-related deaths indicators and NPS.
 ■  European Drug Emergencies Network (Euro-DEN) 
data.
 ■  EMCDDA NPS risk assessments.
 ■  EMCDDA workbooks (national yearly data collection 
tool for qualitative information).
Online expert surveys 
 ■  EMCDDA national focal points.
 ■  EMCDDA trendspotter network.
 ■  Invited experts.
Selected team members were assigned a specific topic 
area, such as NPS in prison, NPS and problem drug users 
or MSM and slamming, and were given the responsibility 
of undertaking a review of the literature and the data 
available in this area.
The online expert surveys were assigned to a single 
member of the team who was dedicated to the 
development, implementation and analysis of the 
questionnaires. The documents were shared with 
the group in the developmental stage and the final 
questionnaires were uploaded onto an online platform 
for easier dissemination and analysis of results. For 
the 2016 trendspotter on PDU and NPS, two different 
questionnaires were created for the two target groups: 
 ■  a short (11 questions) online questionnaire for the 
30 EMCDDA national focal points and the EMCDDA 
trendspotter network; 
 ■  a more comprehensive (40 questions) document, 
which was sent via email to the invited experts. 
Case study example 3 — Looking at methods 
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Facilitating discussion groups or chairing a 
meeting can easily be perceived as tasks of secondary 
importance. However, experience shows that a skilled chair 
or facilitator can make a real difference in the outcome of 
the discussion groups or of the overall meeting. Resources 
on facilitating expert groups or chairing meetings are 
available online. Examples are available on Wikihow’s 
website (‘Run a focus group’) or on Kansas University’s 
website (‘Group facilitation’). These online resources can be 
used to learn some new tips or simply refresh existing 
techniques.
I Identification of expert meeting participants
A strength of the trendspotter methodology is its ability to 
combine scientific literature and data with expert opinion 
collected in a structured way. In phase 2 of data gathering 
and analysis, key experts are invited to attend a meeting 
and make presentations and participate in facilitated 
groups. The selection of experts to be invited to take part in 
the study is extremely important. The team needs to start 
identifying key people with expert knowledge in the area 
right from the outset of the study.
 ■  Key experts can include anybody who could bring 
to the table a substantial piece of information on 
the topic. They can be health and social workers, 
researchers, PhD students, law enforcement 
representatives, drug user representatives, members of 
national focal points, user representatives, investigative 
journalists, etc. 
 ■  Selection criteria for experts — variety is crucial. It 
is important that experts come from a wide range 
of different backgrounds, so that they bring diverse 
viewpoints and expertise to the study. It is a waste if 
any two experts report the same information.
 ■  Another important criterion is linked to the research 
questions: experts should be able to address the 
gaps highlighted by the data gathering exercise of the 
team, i.e. they should be able to answer the questions 
that the team could not (especially level 2 research 
questions).
 ■  Depending on the topic, experts may need to cover 
different geographical locations; for example, different 
country- or city-level perspectives. 
 ■  In the study, it is exactly the rich mix of different 
experiences, views and observations that will help to 
ensure that the results are comprehensive and multi-
layered.
 ■  It is always better to try to find experts who are directly 
involved with the topic under study; for example, a 
front-line worker or ethnographer, rather than someone 
who is involved at a political or administrative level. 
However, sometimes an agency manager is well-
placed to collate and report on all the information they 
have.
 ■  Sometimes, a particular doctor, police officer or 
 ■  Research skills to undertake a literature review and 
implement online surveys.
 ■  Data management and analysis.
 ■  Chairing meetings and time-keeping.
 ■  Facilitating focus groups.
 ■  Synthesis of results.
 ■  Report writing.
Key skills required in a trendspotter study 
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researcher is the one that gets invited by default to all 
meetings, because that expert is widely considered 
to be the ‘key figure in the drugs field’ at national 
level. However, if that key expert does not bring 
any additional value to the topic being studied, the 
coordinator should not feel obliged to invite that expert. 
In other words, do not invite experts ‘by default’ just 
because of their reputation.
 ■  Potential experts to be invited will be discussed by the 
team in an ongoing way. A routine review of who has 
accepted is important, as any gaps in topics or angles 
covered can be identified and a new expert invited.
 ■  A simple table of experts that includes details of their 
nationality, area of expertise, institution and contact 
information is included in the expert meeting planning 
form (Appendix 2). This helps to keep track of experts 
and ensure that all of the important angles are covered.
 ■  Around 10-15 experts is optimal.
For the 2016 trendspotter study on PDU and NPS, 17 
experts were invited with the following characteristics:
 ■  At least one participant representing the topic 
areas of the study. The final selection of experts 
included those with expertise in the following: PDU 
and NPS; harm reduction and NPS; alcohol, drug, 
homeless services and policy; drug policy trends 
and patterns; drug trafficking; drug availability and 
prisons; city-level monitoring of NPS; forensic drug 
analysis; advocacy/EU project; supply/legal issues; 
slamming; and hospital emergencies.
 ■  The countries represented were the Czech 
Republic, Germany, Ireland, France, Latvia, 
Hungary, the Netherlands, Slovenia, Finland, 
Sweden and the United Kingdom.
Case study example 4 — Selection of 
experts
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Key data sources and methods for the study have been 
identified in the planning process. During this phase, the 
information gathering begins. 
The first phase of data gathering and analysis involves the 
use of both qualitative and quantitative methods by the 
team and concludes with a preliminary analysis of results. 
Three mandatory methods are implemented in this phase: 
a literature review, a data review and an online expert 
survey (Figure 3). Further optional methods may be used as 
appropriate.
During this phase, the analysis also begins with the 
team processing, managing and organising the data 
collected. The final analytical output of this phase is a team 
presentation, in which the main findings are summarised 
and presented to the expert meeting according to the 
themes and study framework.
I Literature and data review (mandatory)
The literature and data review provides an overview 
and analysis of available statistics and documentation 
relevant to the topic. It is an essential starting point, but 
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is necessarily limited in scope, given that the focus of the 
study is primarily on new developments. The literature and 
data review also provides an overview of knowledge gaps 
and uncertainties in the subject of interest.
 ■  Before the start of the literature and data review:
 » the list of themes should be agreed upon and 
the research questions should be identified 
(see ‘Identification of main themes’ and 
‘Brainstorming of research questions for each 
theme’, page 17);
 » it is important to define responsibilities 
before the start of this task. The review can be 
undertaken by one team member, or different 
themes can be explored by several team 
members.
Literature review
 ■  The literature review includes scientific publications 
as well as grey literature such as government reports, 
working papers, specialised magazines and news 
articles.
 ■  Examples of possible scientific databases include 
PubMed and Web of Science. Google Scholar and 
Wikipedia can also provide useful entry points into 
scientific and grey literature. 
 ■  The trendspotter methodology is typically used to 
investigate emerging patterns and tendencies, and it 
is therefore important to limit the scope of the review 
rather than undertake a systematic research on the 
topic. 
 ■  Further recommendations.
 » It is important to keep track of key search 
terms and databases searched. This will 
facilitate report writing during the final stage 
of the trendspotter study and retrieving 
literature for further analysis. 
 » Using reference management software, 
such as Endnote or Zotero, can be useful 
for sorting, organising and referencing when 
writing, in particular when different team 
members are involved in the literature and 
data review.
 » Each area that is reviewed results in a short 
paper with references. These can then be 
drawn on for the final report.
Data review
 ■  Where appropriate, existing epidemiological data sets 
may prove to be a useful source of information on 
recent trends and emerging patterns.
 ■  Existing data sets should be reviewed and analysed on 
the basis of the research questions.
 ■  Both European and national routine monitoring data 
are available through, for example, the EMCDDA 
Statistical Bulletin. However, when a new phenomenon 
arises, the time lag between data collection and 
publication may mean that the information available is 
often not timely enough to help understand new and 
emerging trends.
 ■  Additional data sources may be available at a national 
or regional level, including data from nightlife surveys, 
local monitoring, drug checking, wastewater analyses, 
hospital emergencies, etc.
 ■  Results from the data review need to be combined with 
those of the literature review when they focus on the 
same topic.
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I Online expert survey (mandatory)
Before the expert meeting, a detailed questionnaire is 
sent out to those invited through an electronic survey 
programme or through direct email. The objective of the 
online expert survey is to complement the literature and 
data review and to gather data to start to answer (some of) 
the trendspotter research questions. The survey questions 
generally focus more on gathering validation on data 
related to level 1 research questions rather than input on 
level 2 research questions (drivers behind the new trend or 
new phenomenon).
Conducting literature reviews
The literature review may involve searches in several academic databases (including Google Scholar) (see table). 
Google and other search engines such as greynet.org are better for searches of grey literature and academic doctoral 
dissertations; greynet.org has an extensive list of sources for grey literature, categorised by subject. Google News is an 
excellent tool to use to search for news of an issue in a specific temporal window. In addition, Google Alerts allows alerts 
to be set up to monitor the web for interesting new content.
Examples of general and specific databases 
 
Bibliographic/general databases Publisher databases and journal 
websites
Subject-specific databases
Scopus, ISI Web of knowledge, 
Google Scholar, EMBASE, JSTOR, 
ProQuest
ScienceDirect, SpringerLink, Wiley 
Online Library, Oxford Journals
Medline, PsychINFO, MathSciNet, 
arxiv.org, Sociological Abstracts, 
EconLit, ERIC, INSPEC
Use to
 ■  Browse for popular and high-
quality articles
 ■  Start the discovery process and 
find an initial set of papers
Use to
 ■  Browse journals that frequently 
publish on your topics of interest
 ■  Browse journals specific to your 
specialisation
Use to
 ■  Look up articles in a specific 
discipline
 ■  Do in-depth research on a topic
 ■  Look for articles on obscure or 
niche topics
Source: editage.com
Other specific operators include Google, PubMed, Scopus, ISI WOS, ProQuest, PsycINFO, and Science Direct — (see 
the list of academic databases and search engines on Wikipedia).
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 ■  The survey should be mandatory for the experts invited 
to the meeting.
 ■  Surveys are constructed and questions are developed 
according to the study themes and research questions 
(‘Identification of main themes’ and ‘Brainstorming of 
research questions for each theme’, page 17).
 ■  The survey questions cover all themes of the study. 
 ■  Recommended electronic survey programmes are 
SurveyMonkey and LimeSurvey.
 ■  The survey can be developed by one trendspotter team 
member, but it is important to consult the other team 
members, as they may have different insights into or 
knowledge on the trendspotter study topic. 
 ■  The online expert survey can aim to gather both 
qualitative and quantitative information. 
 ■  The questionnaire should start with an introduction to 
the trendspotter study, including the objective of the 
trendspotter study as well as clear survey instructions 
(e.g. information on what is outside the scope of the 
survey). 
 ■  The survey should be short, with a maximum of 15 
questions, preferably mostly multiple-choice questions 
and only some open questions.
 ■  The survey answers are analysed along with the 
findings derived from the literature and data review 
(integration). 
 ■  See Appendix 6 for an example of the survey from the 
2016 EMCDDA trendspotter study. 
I Additional methods (optional)
Alongside the two mandatory methods, further optional 
methods may be applied in a trendspotter study. The use 
of additional methods — e.g. targeted surveys, internet 
snapshots, key informant interviews, social media 
monitoring — will depend on the topic of the study, the 
themes and research questions identified, and the (human 
and financial) resources available.
 ■  Surveys with other relevant expert groups can be a very 
useful additional data collection method; examples 
include groups with particular knowledge on a specific 
theme of the study topic, such as a specialised group 
of practitioners (e.g. doctors in treatment centres, 
nightlife prevention workers), drug users, researchers 
or law enforcement representatives. In all cases 
it will be important to start the questionnaire with 
an introduction, including a brief description of the 
objective of the trendspotter study as well as clear 
survey instructions and how the results will be used. 
The online survey sent to the invited experts can 
provide a useful starting basis for the development of 
the survey for particular expert groups. 
 ■  Internet snapshots can be a useful tool, but they 
require the use of a standardised methodology. Less 
formal approaches might include an exploration of 
forums or specialised websites to help explore and 
understand different aspects of the topic under 
investigation. In some areas this might include 
searching both the surface web and darknet markets.
 ■  Social media may also provide useful information. 
Services such as Twitter and Facebook can be used in 
the information gathering phase to identify potential 
signals and trends.
 ■  If resources allow, it is also possible to commission 
new analyses for this phase. For example, in the 2016 
study, the EMCDDA commissioned a targeted data 
review by the European Drug Emergencies Network 
(Euro-DEN) project on drug-related acute toxicity 
presentations to emergency departments across 
Europe.
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I Analysis
Analysis is a continuous process throughout the study and 
is based on routine team discussions as well as structured 
use of the data collected. To organise and simplify the 
process of data analysis, grids are developed (see ‘Team 
summary presentation’, page 32, and Appendix 7). 
The most important point to make here is that any data 
management option used should allow comparison and 
triangulation in a clear and usable manner.
 ■  Triangulation of data sources checks for congruence/
confirmation (whether findings from different sources 
agree) and for complementarity/completeness 
(whether one set of findings complement and expand 
on those from other sources).
 ■  Triangulation is important to reduce bias, ensure 
validity, improve accuracy, increase confidence in 
results, offset weaknesses of a particular source and 
provide stronger inferences.
 ■  The information resulting from the literature and data 
review as well as the surveys has to be summarised for 
each theme investigated. 
 ■  The combination of the different data sources provides 
the basis and input for the preliminary results of the 
study. These are presented at the expert meeting (team 
summary presentation) and expanded with input from 
expert presentations and facilitated groups during the 
meeting. 
I Use of an ‘analysis grid’ (optional)
In the EMCDDA trendspotter studies, an ‘analysis grid’ 
is a table used to compile results (primarily those of a 
quantitative nature) that are reported from the different 
data sources. The data are summarised according to the 
study framework for easier and more accurate analysis and 
triangulation.
Several weeks before the expert meeting, and while the 
data gathering was ongoing, compiling the results in 
the analysis grid was initiated. Each reported case of 
a specific NPS user group (PDUs/injecting drug user, 
marginalised population, MSM/slammers, prisoners) 
was recorded into the grid by country, along with which 
substances were present and what harms had been 
recorded. A colour scheme helped to differentiate 
between the various sources: literature, EMCDDA 
national focal point, EMCDDA trendspotter network 
and the experts invited to the study meeting (see 
Appendix 7). 
From the resulting analysis grid and triangulation 
with results from the literature review, EU maps were 
constructed to better visualise the results. These results 
were organised into key points by theme and then 
presented in the team summary presentation at the 
expert meeting. 
Case study example 5 — Working with analysis grids in  
the trendspotter study on NPS and PDU
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 ■  The main purpose of an analysis grid is to facilitate the 
analysis and to compile in one single file all the results 
of the data gathering exercise, namely the findings of 
the literature and data review and the survey results.
 ■  Typically, the layout of the grid has the data sources 
in the first column and the variables of the study 
framework along the top row. The data collected are 
placed within the cells.
 ■  Evidence weighting (giving more weight to stronger 
data and discarding/downplaying weaker data) can 
be applied to the data collected and be part of your 
analysis. It is important to use clear criteria to assign 
weight. Examples of weighting factors can be the 
reliability of the source (e.g. published information 
versus media articles) or the reliability of the evidence 
(e.g. something observed versus something just heard).
 ■  The analysis grid can help to create infographics, such 
as heat tables or maps to better visualise the results. 
I Team summary presentation 
The team has to put together a presentation that 
summarises their main findings and pulls together the 
results of the literature and data reviews and online expert 
survey (Figure 4). Generally, the presentation is practised 
and consolidated at one of the regular team meetings 
several weeks before the expert meeting. This allows the 
initial results of the data gathering to be presented within 
the team and provides an opportunity for the whole team 
to discuss and develop hypotheses for the drivers behind 
the new trend, for example. Generally, the team summary 
presentation is structured by themes that were analysed 
during the phase 1 data gathering exercise. Information on 
the main level 2 research questions (one level up) will be 
gathered during the expert meeting and presented in the 
conclusions presentation (see page 37). 
The final team summary presentation will be given at the 
expert meeting (see also Chapter 4). 
FIGURE 4  
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This phase is a key component of the trendspotter 
methodology, using a combination of methods within a 
meeting setting, with the aim of getting a multi-perspective 
insight from individual experts from a wide range of fields. 
The meeting also provides the opportunity to validate 
and fine-tune the findings of the team’s own research 
and data gathering, as well as to bring the findings 
together into a coherent overview on the topic of study. 
Importantly, this phase involves a second data gathering 
exercise, using expert presentations and facilitated groups 
to gather insight to particular broad questions (level 2 
research questions — drivers, implications, challenges, 
etc.) (Figure 5). Towards the end of the expert meeting, 
the trendspotter team shares its findings in the form of 
the team presentation developed earlier and finishes the 
meeting with the conclusions presentation.
I  Planning the expert meeting
Ideally the meeting will last for 1.5 days, although it can be 
limited to a single day.
The first (full) day is dedicated to expert presentations 
and facilitated groups. The second (half) day will include 
feedback from the facilitated groups, the team presentation 
FIGURE 5
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with the results of the data gathering from phase 1 and, 
finally, a conclusions presentation (page 37). It may 
be that, because of the professional engagements of the 
experts or limited financial resources, the meeting can 
only last 1 day. In this case, it is important to organise the 
agenda accordingly and allow enough time for crucial 
methodological steps to be included in the timing (see 
page 37). 
Prior to the meeting
 ■  The team needs to send invitations to experts well in 
advance of the meeting. 
 ■  The meeting agenda (Appendix 3) and guidelines 
for expert presentations (Appendix 4) need to be 
sent out, including a reminder about the length of 
presentations (including maximum number of slides), 
the requirement to send presentations at least some 
days before the meeting, and a note about the tight 
schedule of the meeting. 
Day of the meeting
 ■  The last team meeting before the expert meeting 
should be dedicated to fine-tuning the preparations 
and the team members’ participation during the expert 
meeting. Tasks to be assigned include note-taking 
during the meeting, assisting with timekeeping and 
facilitating groups. It is also the time to agree on the 
composition of the facilitated groups, the facilitators, 
the set of questions for each group, and so on. 
 ■  At the start of the meeting, it is important to briefly 
explain the trendspotter methodology and the experts’ 
role within this methodology.
 ■  If the expert meeting takes place over 1.5 days, a social 
event (i.e. dinner) should be planned for the end of the 
first day to help continue the discussion and provide 
an opportunity to further develop rapport with experts. 
If the expert meeting takes place only over 1 day, some 
time should be allowed for experts to socialise and 
interact with each other. 
 ■  The priority of the meeting is to gather as much 
information as possible from the experts rather than 
showcase the team’s knowledge on the topic. The 
members of the trendspotter team need to be briefed 
to not interfere during the meeting but rather to listen 
carefully to the experts and facilitate discussions and 
not come in too early or at all with their own opinions.
 ■  Colleagues not involved in the trendspotter study may 
also want to attend the meeting. It is important that 
their role remains as observers and not as contributors 
to the discussions and they should be briefed on this 
beforehand. 
 ■  It is crucial that the trendspotter team is perceived 
as neutral and unbiased by the experts to allow open 
discussion at the meeting. 
 ■  It is recommended that the chair asks that information 
provided and discussed within the meeting stay 
confidential, with no social media posts, tweets, etc. of 
what is being discussed. The reason for this is that this 
is a working meeting, one that forms part of a study, 
and participants need to feel safe to discuss topics 
without fear of being individually cited.
 ■  It is advised that someone from the team assists the 
chair with time-keeping and floor management. The 
EMCDDA uses a yellow and red card system (with 
some humour), whereby the assistant holds up the 
yellow card at 8 minutes into the presentation and 
the red card at 10. It is of course important to remain 
flexible with this system and to avoid interrupting the 
expert during important points or closing remarks.
Chapter 4 I  Data collection and analysis (phase 2): the expert meeting 
37
I Expert presentations
All experts give short presentations on day 1 of the 
meeting. Experts are sent guidelines on presenting 
in advance. The aim of the guidelines is to keep the 
presentations brief and structured, and to maintain the 
focus of the discussion on the study itself and on the area 
of expertise of the particular expert. 
 ■  The best order of expert presentations, by topic (e.g. 
supply and production-related presentations, health-
related presentations, etc.) or mixed, needs to be given 
some thought. 
 ■  Additional time for a couple of questions should be 
reserved after each presentation; however, these 
questions should be about clarification and not lead to 
an overall discussion on the topic.
 ■  About 15-30 minutes should be allocated for general 
discussion after each series of topical presentations.
 ■  Team members taking notes on the experts’ input is 
crucial, as it provides additional information that can 
feed into the conclusions presentation. 
I Facilitated groups
The second part of day 1 is dedicated to facilitated groups. 
The participants are divided into two or three groups 
according to the number of experts invited, with two 
facilitators from the team in each group. One team member 
will facilitate the group and the other will take detailed 
notes. 
 ■  Groups can be mixed or have professional 
backgrounds in common. Both topical and mixed 
facilitated groups have advantages and limitations. The 
trendspotter team needs to decide which composition 
will work best. 
 ■  Often, each group will receive the same set of 
questions that has been prepared before the meeting 
(Appendix 5). Sometimes, however, questions will vary 
(e.g. market-related questions to a law enforcement 
group). 
 ■  Questions are generally level 2 in nature (one level 
up — drivers, dynamics, implications, challenges, 
implications, etc.) compared with those that have 
already been reviewed during phase 1 (level 1 
questions). These questions are crucial for the 
conclusions presentation.
 ■  The facilitator needs to ask one of the experts to act as 
a rapporteur. It is important to do this at the start so the 
rapporteur can make notes.
 ■  At the end of the group session, it is helpful if the 
facilitator summarises the main findings to assist the 
rapporteur.
 ■  After the facilitated group sessions have finished, the 
rapporteurs present the feedback in plenary.
Usually, at the expert meeting, one of the team members 
presents the team summary right after the feedback from 
the facilitated groups. Depending on the topic or the time 
available, the team summary presentation may, however, 
be given earlier in the meeting, after the presentation of the 
trendspotter methodology. 
I Conclusions presentation
Towards the end of the meeting, the team members need 
to meet briefly to discuss the outcomes from the facilitated 
groups and expert presentations on the key questions of 
the trendspotter study, and to draft a conclusions 
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presentation (Figure 6; see also Chapter 1). This discussion 
on the conclusions presentation can be held at the end of 
day 1 (if it is a 1-day meeting, then possibly during the last 
30-minute coffee break), but importantly, it takes place 
after the expert presentations and facilitated groups. 
 ■  The conclusions presentation summarises key study 
findings, building on the phase 1 analysis plus expert 
presentations and common threads in discussions 
from the facilitated groups (level 2 questions). 
 ■  The presentation should be relatively short (maximum 
10 slides).
 ■  After the presentation is made (by the team leader 
or another team member) time should be set aside 
for a final round table and general discussion with all 
participants to provide a last opportunity for remarks 
and clarification. These discussions can be vital in 
forming solid and coherent conclusions on the overall 
topic of investigation for both the trendspotter team 
and the experts. 
Think of the conclusions presentation as an 
‘elevator speech’ that you need to give to a politician in a 
short period of time. You may therefore structure it 
according to headlines such as: ‘What is happening?’, 
‘What are the drivers?’, ‘What are the challenges?’ and 
‘What are the implications for policy and practice?’
FIGURE 6
Conclusion presentation process
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For the 2016 trendspotter study, 17 experts were invited. 
They were contacted between August and September. 
The agenda for the event and the guidelines for the 
experts’ presentations were prepared a month before 
the event. The aim of the guidelines was to keep the 
presentations brief and structured on the topic of study. 
Experts were asked to focus on their area of expertise 
and organise their presentation around the following 
points: 
1.  main PDU groups using NPS in your city/country 
(e.g. injectors, prisoners, MSM, homeless);
2.  patterns and trends in problem drug users and NPS;
3.  main NPS substances/products used;
4.  associated harms and deaths;
5.  sources/supply of NPS;
6.  external triggers linked with the new use or changes 
in use patterns or stopping use; 
7.  unmet need for health and social interventions.
After the round of presentations, the experts were 
divided into three groups with two EMCDDA facilitators/
observers in each group. Questions were prepared in 
advance, based on the study themes and research 
questions best answered in this group setting. For the 
trendspotter study on HRDU and NPS the following 
questions were asked:
 ■  What clusters of PDU/NPS use can be identified in 
Europe, for example, linked with opioids, prisons, etc. 
(please detail/draw)?
 ■  How might we describe the role of NPS in the overall 
PDU market — a major product, replacement, minor 
player?
 ■  Do different NPS (opioids, cathinones, cannabinoids) 
play different roles in national problem drug markets 
— what are these?
 ■  What lies behind, and is fuelling, the different 
European clusters of problem NPS use?
 ■  What new and emerging trends are observable in 
this area? 
 ■  How would you characterise the main information 
gaps and monitoring challenges in this area (at the 
European and national level)?
 ■  Responses — what implications do you see for 
health and social responses?
 ■  Overall, how concerned should we be about problem 
use of NPS in Europe — a relatively minor issue or a 
growing threat and priority area?
The key findings of the focus group were gathered by a 
rapporteur (one expert was nominated in each facilitated 
group) who presented a summary in plenary.  
Case study example 6 — Data gathering and analysis at the expert meeting
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Pulling together the results of phase 1 of data gathering 
(i.e. the analysis grid and summary presentation) with the 
results of phase 2 (i.e. expert meeting and conclusions 
presentation) the team prepares a final report on the study. 
It is important to develop a dissemination strategy to make 
sure that the final output reaches as many potential targets 
as possible. 
The final report should be available within 2-3 months of 
the expert meeting and should concise — around 15-20 
pages. It needs to cover the methods used in the study, 
the main results of the analysis and a summary of the 
conclusions. 
I Report writing
The team member assigned to the report writing task 
should be identified early in the planning process and, once 
the expert meeting is over, they will need to coordinate all 
the different inputs from the team including the final data 
check and analysis.
 ■  All team members who undertook literature reviews 
and analyses will be asked to rapidly provide short 
summaries (one to two pages for their area) so that 
the report writer can collate these. Original literature 
reviews will need to be supplemented by any new data 
gathered at the meeting. Important new findings from 
the presentations and the facilitated groups need to be 
incorporated.
 ■  The report will need a methods section explaining 
the study process and analysis. Refer to published 
EMCDDA reports for examples.
Where the literature has been used, a reference should be 
cited in the report. Where data comes from expert opinion, 
this can also be included. For example, ‘A law enforcement 
expert told …’ or ‘Information from user advocacy groups 
suggests …’
 ■  Experts are thanked by name in the acknowledgements 
but not cited as individuals in the text.
 ■  The time needed to complete the report will vary 
depending on the resources allocated as well as the 
final format it will take.
 ■  The report needs to be short to be published within the 
timeframe.
 ■  A draft of the report will need to be reviewed both by all 
trendspotting team members and by the participants 
of the expert meeting.
I Launch and dissemination
During the planning process, it is important to identify the 
dissemination strategy and launch plans for the final report. 
CHAPTER 5
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 ■  Suggestions for dissemination:
 » Rapid communications and other reporting 
mechanisms (other institutional publications);
 » publications in peer-reviewed journals, web 
content, social media outputs, etc.;
 » specific launch event (conference or dedicated 
event).
For the 2016 trendspotter study, the work on the report 
started immediately after the expert meeting. Each 
trendspotter team member was asked to provide the 
results of their own thematic literature review and a 
summary of the main points. The team leader, with 
the assistance of an intern, developed a first draft 
which was then circulated for feedback, first among 
the trendspotter team and then, in a second round, 
to the participants of the expert meeting. Comments 
were incorporated, and after a second round of review 
among the trendspotter team, the final document 
was sent for production after the final approval of the 
Scientific Director. The report was developed as a 
downloadable PDF file, which could be printed and also 
uploaded onto the EMCDDA publication website.
Case study example 7 — Report writing
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APPENDIX 1
Planning form template
Topic for the study
Rationale
Aim
Objectives
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Themes
Research questions
Team members’ roles
Proposed methods
Proposed outputs
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APPENDIX 2
Expert meeting planning form template
Expert meeting
Location
Proposed date
Available budget
Expert invitees
Name Nationality Area of 
expertise
Institution Contact details
1
2
3
4
5
6
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APPENDIX 3
Expert meeting agenda template
44
AGENDA 
Date (time)
Morning session
08.30-08.45 Registration 
09.00-09.30 Welcome and introduction to trendspotter methodology
09.30-10:30 Expert presentations (number of presenters)  
- Names of presenters (organisation names) 
Time (30 min)  Coffee break  
11.00-12.30 Expert presentations x 6  
- Names of presenters (organisation names) 
12.30-12.45 Discussion 
Time (75 min)  Lunch break
Afternoon session
14.00-15.30 Expert presentations x 6 
- Names of presenters (organisation names) 
Time (30 min)  Coffee break 
16.00-17.30 Facilitated working groups (number of groups) 
19.30 — Social event 
Date (time)
09.00-10.00 Feedback from facilitated groups in plenum  
10.00-11.00 Summary of presentation by trendspotting team  
Time (20 min) Coffee break 
11.20-11.40 Round table 
11.40-12.30 Conclusion presentation by trendspotting team
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 APPENDIX 4
Guidelines for expert presentations template
Guidelines for presentations for (insert study title)
Timing of presentation: (time)
Number of slides: (number)
Find below suggested indications for your presentation. 
Please focus on your area of expertise:
1. Example: Main problem drug use groups using new psychoactive substances in your 
city/country (e.g. injectors, prisoners, men who have sex with men, homeless).
2. Recent patterns, groups and trends in use of ‘name of substance’ in your city/
country.
3. Supply and trafficking of ‘name of substance’.
4.  Harms and deaths associated with ‘name of substance’ and health responses.
Definitions used in this meeting
Study topic — the trendspotter study will focus on:
1. Topic area 
2. etc. 
We are not focusing on — (excluded topic areas)
Please send a copy of your presentation to (name of contact person and contact details) by 
(date) 
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APPENDIX 5
Facilitated group questions template
Based on all the presentations you have heard on recent trends in ‘name of substance’ and 
drawing on your own experience: 
1.  What clusters of at-risk user groups can be identified in your country?  
(Please detail/draw.)
2.  How might we describe the role of ‘name of substance’ in the overall high-risk drug 
use market: a major product, replacement, minor player?
3.  Do different ‘name of substance’ products play different roles in the national drug 
market — what are these?
4.  Are we seeing new business models and players in the trafficking and distribution of 
‘name of substance’ in your country?
5.  What new and emerging trends are observable in this area? 
6.  How would you characterise the main information gaps and monitoring challenges 
in this area (at national and regional levels)?
7.  Responses — what implications do you see for health and social responses?
8.  Overall, how concerned should we be about use of ‘name of substance’ — is it a 
relatively minor issue or a growing threat and priority area?
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APPENDIX 6
Trendspotter expert survey template
Dear expert,
Thank you for agreeing to attend the trendspotter meeting on ‘insert study topic’.
We are asking all attendees to complete a questionnaire on this topic. The focus is on 
developments in ‘insert study topic’ market occurring in the last two years.
Please answer all questions based on your expert observations in the setting and 
geographical area where you work. 
Definition of study topic: ‘insert here’
Please list the sources of your answers (survey, studies, expert opinion, media, etc.) in the 
comment boxes.
We would appreciate if you could complete the survey by the ‘insert date’.
Name: (Survey respondent should insert here their name) 
Country/region/city name: (Survey respondent should insert here their geographical 
location)
Professional background: (Survey respondent should insert here their professional 
background)
‘Substance name’ supply and use
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[1] Have there been changes in the availability of ‘substance name’ over the last two years? 
Please choose only one of the following:
 ■  Strong decrease 
 ■  Slight decrease 
 ■  No change 
 ■  Slight increase 
 ■  Strong increase 
 ■  Don’t know 
Make a comment on your choice here: 
[2] Have there been changes in the prevalence of ‘substance name’ use  
over the last two years? 
Please choose only one of the following:
 ■  Strong decrease 
 ■  Slight decrease 
 ■  No change 
 ■  Slight increase 
 ■  Strong increase 
 ■  Don’t know 
Make a comment on your choice here: 
[3] Which specific groups have recently been associated with ‘substance name’? 
Please choose (multiple answers possible):
 ■  Socially integrated young adults
 ■  Men who have sex with men (MSM)
 ■  Partygoers/clubbing milieu
 ■  Injecting and/or high risk drug users
 ■  Homeless – highly marginalised groups
 ■  Ethnic minorities/migrants 
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 ■  Don’t know
 ■  Other (please specify): 
 ■  No change observed among any specific group
Make a comment on your choice(s) here: 
[4] Are there particular patterns of use and particular risk behaviours that are associated 
with ‘substance name’ among these groups (e.g. injecting, polydrug use, binging, etc.)?
Please write your answer here:
[5] How would you describe the geographical spread of ‘substance name’? 
 ■ Use is occasional and dispersed across the country (urban and rural) 
 ■ Use is restricted to a few clusters in particular regions (primarily urban)
 ■ Use is widespread across the whole country (urban and rural).
 ■ Don’t know   
 ■ Other (please specify):
Make a comment on your choice(s) here: 
[6] Have you noticed any significant overlaps or links between the ‘substance name’ and 
other illicit drug markets e.g. amphetamine, heroin, NPS, etc.?
Please comment here: 
[7] What market and social factors may be associated with changes in ‘substance name’ 
use and availability (e.g. drug shortages, changes in drug availability, drug legislations, 
product purity, prices, new technologies, etc.)?
Please write your answer here:
[8] Have there been changes in non-fatal intoxications associated with ‘substance name’ 
over the last two years? 
Please choose only one of the following:
 ■  Strong decrease 
MANUALS I Trendspotter manual: a handbook for the rapid assessment of emerging drug-related trends
54
 ■  Slight decrease 
 ■  No change 
 ■  Slight increase 
 ■  Strong increase 
 ■  Don’t know 
Make a comment on your choice:
[9] Have there been changes in the number of deaths due to ‘substance name’ over the last 
two years? 
Please choose only one of the following:
 ■  Strong decrease 
 ■  Slight decrease 
 ■  No change 
 ■  Slight increase 
 ■  Strong increase 
 ■  Don’t know 
Make a comment on your choice 
In the comment box please also list the sources of the information (survey, studies, expert 
opinion, media, etc.). 
[10] If there have been recent outbreaks of harm/deaths related to ‘substance name’, 
please provide more details, e.g. type of product, purity, specific risk behaviours, 
characteristics of the cases, etc.
Please write your answer here:
[11] Other comments regarding ‘substance name’
Please write your answer here: 
Thank you for completing this survey.
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APPENDIX 7
Analysis grid template
Availability
Seizures 
(Number)
Seizures 
(Amount) Purity
General 
population 
survey / 
use
Treatment 
demands
Drug 
checking
Waste-
water 
analysis
 Non-fatal 
intoxications 
Trends in 
deaths
No of 
deaths with 
'substance 
name' 
mentioned
or 
implicated
'Your 
organisation'
n.a. Strong 
increase
Strong 
increase
Strong 
increase
Strong 
increase
Strong 
increase
Strong 
increase
n.a. n.a.
Expert 1 Increase Increase Increase n.a. Increase Increase Stable
Expert 2 Strong 
increase
Strong 
increase 
Stable Stable Stable Stable n.a. Stable Stable n.a.
etc.
Literature 
review
Strong 
increase
Strong 
increase 
Increase Stable Increase n.a. n.a. Stable Stable Stable
Ad-hoc survey 
with users
Increase n.a. n.a. Increase Strong 
increase
n.a. n.a. n.a. don't know don't 
know
Increase
Other data Increase Decrease Increase Decrease Increase Stable n.a. n.a. Strong 
increase
Strong 
increase
40 
registered 
cases in 
this region
Local 
monitoring 
n.a. n.a. n.a. n.a. Increase Stable Increase n.a. Increase Increase
Add any other 
data sources
Sources Methods (example)
'Your 
organisation' Epidemiological indicators, in-house information Strong increase: ≥ 30 % increase
Expert Results of online expert survey Increase: > 10 % increase and less than 30 %
Literature 
review Results of media and grey literature Stable: ≤ 10 % rise or reduction
Other Results of ad hoc surveys (e.g. treatment centres) Decrease: > 10 % reduction and less than 30 % reduction
Local 
monitoring 
Drug-checking services or 
drug consumption rooms Strong decrease: ≥ 30 % reduction
Recent (2 years) changes in ‘substance name’ market 
Sources SUPPLY USE HARMS
Increase Increase Increase Increase
Increase
Increase Increase
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GETTING IN TOUCH WITH THE EU
In person
All over the European Union there are hundreds of Europe Direct 
information centres. You can find the address of the centre nearest you at:  
http://europa.eu/contact
On the phone or by e-mail
Europe Direct is a service that answers your questions about the  
European Union. You can contact this service 
•  by freephone: 00 800 6 7 8 9 10 11  
(certain operators may charge for these calls) 
•  at the following standard number: +32 22999696 or
•  by electronic mail via: http://europa.eu/contact
FINDING INFORMATION ABOUT THE EU
Online
Information about the European Union in all the official languages of the 
EU is available on the Europa website at: http://europa.eu 
EU publications
You can download or order free and priced EU publications from EU 
Bookshop at: http://bookshop.europa.eu.  
Multiple copies of free publications may be obtained by contacting Europe 
Direct or your local information centre (see http://europa.eu/contact)
EU law and related documents
For access to legal information from the EU, including all EU law since 
1951 in all the official language versions, go to EUR-Lex at: 
http://eur-lex.europa.eu
Open data from the EU
The EU Open Data Portal (http://data.europa.eu/euodp/en/data)  
provides access to datasets from the EU. Data can be downloaded and 
reused for free, both for commercial and non-commercial purposes.
About this publication
This publication is a user-friendly guide, taking the reader, step by step, 
through the trendspotter methodology developed by the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) to explore 
emerging drug trends, new patterns of use, developing drug markets and 
technologies. The trendspotter method involves the rapid collection and 
triangulation of data from a variety of sources, incorporating multiple 
social research methods, and drawing on rapid assessment and response 
methods. This manual is aimed at national and international agencies 
and organisations working in the drugs field, including research groups, 
community organisations, government agencies or professionals interested 
in applying the trendspotter methodology to rapidly identify, assess and 
inform about emerging drug trends.
About the EMCDDA
The EMCDDA is the central source and confirmed authority on drug-related 
issues in Europe. For over 20 years, it has been collecting, analysing and 
disseminating scientifically sound information on drugs and drug addiction 
and their consequences, providing its audiences with an evidence-based 
picture of the drug phenomenon at European level. 
